Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1986 3
1988 4
1989 2
1990 2
1991 1
1992 2
1993 2
1994 1
1995 1
1996 2
1997 5
1998 4
1999 3
2000 6
2001 6
2002 8
2003 9
2004 8
2005 8
2006 9
2007 4
2008 13
2009 7
2010 15
2011 13
2012 17
2013 13
2014 16
2015 17
2016 20
2017 24
2018 21
2019 23
2020 27
2021 26
2022 19
2023 18
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Results by year

Filters applied: . Clear all
Page 1
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS. Petri M, et al. Among authors: magder ls. Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473. Arthritis Rheum. 2012. PMID: 22553077 Free PMC article.
Reply.
Petri M, Joyce D, Haag K, Fava A, Goldman DW, Zhong D, Xiao S, Milstone A, Magder LS. Petri M, et al. Among authors: magder ls. Arthritis Care Res (Hoboken). 2023 Oct;75(10):2225. doi: 10.1002/acr.25109. Epub 2023 Apr 26. Arthritis Care Res (Hoboken). 2023. PMID: 36861682 No abstract available.
Reply.
Petri M, Magder LS. Petri M, et al. Among authors: magder ls. Arthritis Rheumatol. 2021 Nov;73(11):2149-2150. doi: 10.1002/art.41880. Epub 2021 Sep 2. Arthritis Rheumatol. 2021. PMID: 34042333 No abstract available.
Reply.
Petri M, Elkhalifa M, Magder LS, Li J, Goldman DW. Petri M, et al. Among authors: magder ls. Arthritis Rheumatol. 2021 Feb;73(2):359. doi: 10.1002/art.41521. Epub 2020 Dec 24. Arthritis Rheumatol. 2021. PMID: 32936524 No abstract available.
Reply.
Petri M, Li J, Elkhalifa M, Magder LS, Goldman DW. Petri M, et al. Among authors: magder ls. Arthritis Rheumatol. 2020 Dec;72(12):2166. doi: 10.1002/art.41462. Epub 2020 Oct 7. Arthritis Rheumatol. 2020. PMID: 32741151 No abstract available.
Reply.
Petri M, Li J, Magder LS, Goldman DW. Petri M, et al. Among authors: magder ls. Arthritis Rheumatol. 2020 Apr;72(4):694. doi: 10.1002/art.41146. Epub 2020 Feb 11. Arthritis Rheumatol. 2020. PMID: 31631561 No abstract available.
Reply.
Petri M, Magder LS. Petri M, et al. Among authors: magder ls. Arthritis Rheumatol. 2018 Dec;70(12):2099. doi: 10.1002/art.40693. Epub 2018 Sep 24. Arthritis Rheumatol. 2018. PMID: 30120905 No abstract available.
Effect of a Multicomponent Home-Based Physical Therapy Intervention on Ambulation After Hip Fracture in Older Adults: The CAP Randomized Clinical Trial.
Magaziner J, Mangione KK, Orwig D, Baumgarten M, Magder L, Terrin M, Fortinsky RH, Gruber-Baldini AL, Beamer BA, Tosteson ANA, Kenny AM, Shardell M, Binder EF, Koval K, Resnick B, Miller R, Forman S, McBride R, Craik RL. Magaziner J, et al. Among authors: magder l. JAMA. 2019 Sep 10;322(10):946-956. doi: 10.1001/jama.2019.12964. JAMA. 2019. PMID: 31503309 Free PMC article. Clinical Trial.
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis.
Fava A, Buyon J, Magder L, Hodgin J, Rosenberg A, Demeke DS, Rao DA, Arazi A, Celia AI, Putterman C, Anolik JH, Barnas J, Dall'Era M, Wofsy D, Furie R, Kamen D, Kalunian K, James JA, Guthridge J, Atta MG, Monroy Trujillo J, Fine D, Clancy R, Belmont HM, Izmirly P, Apruzzese W, Goldman D, Berthier CC, Hoover P, Hacohen N, Raychaudhuri S, Davidson A, Diamond B; Accelerating Medicines Partnership in RA/SLE network; Petri M. Fava A, et al. Among authors: magder l. JCI Insight. 2024 Jan 23;9(2):e172569. doi: 10.1172/jci.insight.172569. JCI Insight. 2024. PMID: 38258904 Free PMC article.
Urine proteomic insights from the belimumab in lupus nephritis trial.
Weeding E, Fava A, Mohan C, Magder L, Goldman D, Petri M. Weeding E, et al. Among authors: magder l. Lupus Sci Med. 2022 Sep;9(1):e000763. doi: 10.1136/lupus-2022-000763. Lupus Sci Med. 2022. PMID: 36167482 Free PMC article. Clinical Trial.
346 results